Duncan HJ - Search Results

1

Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.

Nicolaou SA, Neumeier L, Takimoto K, Lee SM, Duncan HJ, Kant SK, Mongey AB, Filipovich AH, Conforti L. Nicolaou SA, et al. Among authors: duncan hj. Cell Calcium. 2010 Jan;47(1):19-28. doi: 10.1016/j.ceca.2009.11.001. Epub 2009 Dec 2. Cell Calcium. 2010. PMID: 19959227 Free PMC article.

2

Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus.

Nicolaou SA, Szigligeti P, Neumeier L, Lee SM, Duncan HJ, Kant SK, Mongey AB, Filipovich AH, Conforti L. Nicolaou SA, et al. Among authors: duncan hj. J Immunol. 2007 Jul 1;179(1):346-56. doi: 10.4049/jimmunol.179.1.346. J Immunol. 2007. PMID: 17579055 Free PMC article.

3

Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus.

Khodoun M, Chimote AA, Ilyas FZ, Duncan HJ, Moncrieffe H, Kant KS, Conforti L. Khodoun M, et al. Among authors: duncan hj. Sci Adv. 2020 Nov 18;6(47):eabd1471. doi: 10.1126/sciadv.abd1471. Print 2020 Nov. Sci Adv. 2020. PMID: 33208373 Free PMC article.

4

External beam radiation therapy for PTFE dialysis grafts: a pilot study.

Roy-Chaudhury P, Duncan HJ, Zuckerman D, Faiyaz R, Munda R, Kant S, Kelly B, Narayana A. Roy-Chaudhury P, et al. Among authors: duncan hj. J Vasc Access. 2012 Jul-Sep;13(3):329-31. doi: 10.5301/jva.5000052. J Vasc Access. 2012. PMID: 22287221 Clinical Trial.

5

Alternative medicine use in dialysis patients: potential for good and bad!

Duncan HJ, Pittman S, Govil A, Sorn L, Bissler G, Schultz T, Faith J, Kant S, Roy-Chaudhury P. Duncan HJ, et al. Nephron Clin Pract. 2007;105(3):c108-13. doi: 10.1159/000097986. Epub 2006 Dec 15. Nephron Clin Pract. 2007. PMID: 17179733

6

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

Lewis JB, Sika M, Koury MJ, Chuang P, Schulman G, Smith MT, Whittier FC, Linfert DR, Galphin CM, Athreya BP, Nossuli AK, Chang IJ, Blumenthal SS, Manley J, Zeig S, Kant KS, Olivero JJ, Greene T, Dwyer JP; Collaborative Study Group. Lewis JB, et al. J Am Soc Nephrol. 2015 Feb;26(2):493-503. doi: 10.1681/ASN.2014020212. Epub 2014 Jul 24. J Am Soc Nephrol. 2015. PMID: 25060056 Free PMC article. Clinical Trial.

7

Parathyroid hormone suppression by intravenous calcitriol: role of phosphate, calcium, race and diabetes.

Kant KS, Cook EF, Duncan H, Freyberg R. Kant KS, et al. Am J Med Sci. 2002 Apr;323(4):210-5. doi: 10.1097/00000441-200204000-00008. Am J Med Sci. 2002. PMID: 12003377

8

Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.

El-Khatib M, Duncan HJ, Kant KS. El-Khatib M, et al. Among authors: duncan hj. Nephrology (Carlton). 2006 Oct;11(5):400-4. doi: 10.1111/j.1440-1797.2006.00676.x. Nephrology (Carlton). 2006. PMID: 17014552

9

Combining novel technologies with improved logistics to reduce hemodialysis vascular access dysfunction.

Roy-Chaudhury P, Lee T, Duncan H, El-Khatib M. Roy-Chaudhury P, et al. J Vasc Access. 2009 Jan-Mar;10(1):1-4. doi: 10.1177/112972980901000101. J Vasc Access. 2009. PMID: 19340792 Review.

10

Hemodialysis vascular access dysfunction from basic biology to clinical intervention.

Roy-Chaudhury P, Kelly BS, Narayana A, Desai P, Melhem M, Munda R, Duncan H, Heffelfinger SC. Roy-Chaudhury P, et al. Adv Ren Replace Ther. 2002 Apr;9(2):74-84. doi: 10.1053/jarr.2002.33519. Adv Ren Replace Ther. 2002. PMID: 12085383 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page